BECKY TENNISON: Open Payments
NPI 1013599687 · LIVINGSTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 45 payments from 12 companies in 2025. Trend: 2023 $1,077 · 2024 $489 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $193 |
| Axsome Therapeutics, Inc. | 6 | $139 |
| ABBVIE INC. | 5 | $86 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Lilly USA, LLC | 3 | $52 |
| PFIZER INC. | 2 | $41 |
| Novo Nordisk Inc | 2 | $33 |
| Alkermes, Inc. | 1 | $21 |
| Phadia US Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $17 |
Products named: CAPLYTA, Auvelity, REXULTI, VRAYLAR, MOUNJARO, PREVNAR 20, VIVITROL, ImmunoCAP.
Industry payments across LA — which companies pay providers there.
